Opioid cessation products under attack by FTC & FDA

Together with the FDA, the FTC issued joint warning letters to 11 marketers and producers of allegedly unapproved opioid cessation products.  The letters allege that the companies used online platforms to make unsubstantiated claims about their products’ ability to treat opioid addiction and withdrawal.  Letters were sent to: Opiate Freedom Center (Opiate Freedom 5-Pack) U4Life, […]

HHS website usability guidelines used by FTC to allege misleading marketing practices

Trial began on last week for a deceptive advertising suit against DirecTV in which the FTC’s opening statements asked the Court to award $3.95 in damages to consumers.

Finally: A Statute of Limitations on FTC Disgorgement Actions?

On June 5, 2017, the Supreme Court of the United States decided Kokesh v. SEC, No. 16-529, holding that disgorgement claims must be commenced within five years of the claims’ accrual because such claims operate as penalties.